Oxygen Biotherapeutics, Inc. Builds New Relationships for Dermacyte Products and Traumatic Brain Injury Clinical Trials

May 19, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DURHAM, N.C., May 19, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced today that the Company has formalized working relationships with an international cosmetic company and a site monitoring company.

Twitter
LinkedIn
Facebook
Email
Print

Alliances

Tenax Therapeutics